Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avasopasem Manganese + SBRT in Locally Advanced Pancreatic Cancer
NCT03340974Phase 2Completed
- Sponsor
- Galera Therapeutics, Inc.
- Start
- Feb 2018
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of avasopasem manganese in pancreatic adenocarcinoma (PDAC), sponsored by Galera Therapeutics, Inc.. Started Feb 2018; status: completed.
02
Drugs
avasopasem manganese
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03340974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03340974.